MARGARET SOHMER: Open Payments
NPI 1578346300 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,795 in 87 payments from 20 companies in 2025. Trend: 2023 $1,369 · 2024 $5,883 · 2025 $2,795
Food & beverage: $2,629Education: $166
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 13 | $651 |
| Janssen Biotech, Inc. | 16 | $435 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 6 | $412 |
| GENZYME CORPORATION | 7 | $329 |
| UCB, Inc. | 10 | $242 |
| ABBVIE INC. | 9 | $164 |
| Novartis Pharmaceuticals Corporation | 5 | $113 |
| Incyte Corporation | 4 | $75 |
| Organon LLC | 4 | $64 |
| Regeneron Healthcare Solutions, Inc. | 2 | $64 |
Products named: NEMLUVIO, TREMFYA, DUPIXENT, ILUMYA, Bimzelx, SKYRIZI, OPZELURA, COSENTYX.
Industry payments across TN — which companies pay providers there.
